NCT01411566
Unknown
Early Phase 1
Evaluation of an Integrative Therapeutic Concept for Schizophrenic Patients With Comorbid Substance Use Disorder
Overview
- Phase
- Early Phase 1
- Intervention
- Not specified
- Conditions
- Psychosis
- Sponsor
- University of Cologne
- Enrollment
- 122
- Locations
- 1
- Primary Endpoint
- Substance use
- Last Updated
- 14 years ago
Overview
Brief Summary
The purpose of this study is to evaluate an integrative therapeutic concept for schizophrenic patients with comorbid substance use disorder.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Schizophrenia
- •Addiction
- •Written statement of agreement
Exclusion Criteria
- •Acute psychosis
- •Further neuropsychiatric disorder
Outcomes
Primary Outcomes
Substance use
Time Frame: 6 months
Change in drug use motivation
Time Frame: 1 year
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
Efficacy of Repyflec Cognitive Remediation Group Training in SchizophreniaIndication for Modification of Patient Cognitive StatusNCT01279070Fundació Sant Joan de Déu62
Completed
Not Applicable
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)AutismNCT02154828Nantes University Hospital103
Completed
Not Applicable
Validating Clinical Efficacy for Integrated Psychological Intervention for Obesity: Physical Therapy and PsychotherapyMental Health IssueBody ImageNCT04199611Seoul National University Hospital160
Completed
Phase 2
Integrative Medicine Approach to the Management of Asthma in AdultsAsthmaNCT00843544Beth Israel Medical Center156
Recruiting
Not Applicable
Integrated Care in Psychotic Disorders With Severe Mental IllnessSchizophreniaSchizophreniform DisorderSchizoaffective DisorderDelusional DisorderPsychotic Disorder NOSBipolar DisorderSevere Major Depression With Psychotic FeaturesNCT01888627Universitätsklinikum Hamburg-Eppendorf400